FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere
French drug maker Sanofi-Aventis SA announced on Thursday that the US Food and Drug Administration has approved its cancer drug Taxotere to treat patients with stomach cancer.// This approval means that Taxotere can be used in combination with chemotherapy drugs cisplatin and 5-fluorouracil to treat stomach cancers that have not been treated with chemotherapy. Taxotere is also approved...Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
Sanofi-Aventis SA has announced that it has begun the clinical trials of a purported vaccine for the H7N1 bird flu strain, a different but equally ferocious strain that// could spark off a potential pandemic. 60 adults at the Haukeland University Hospital in Bergen, Norway will be subjects of the clinical trials to be conducted by Sanofi Pasteur. The H5N1 strain of bird flu virus had...Sanofi-Aventis Allows Thais To Make Plavix
The generic version of Plavix, the heart disease medicine of Sanofi-Aventis will be made indigenously in Thailand. This was announced by the pharma company on Tuesday.// As per the offer made by Sanofa-Aventis, the health ministry has approved plans to buy or make imitated version of the drug. The statement released by the drug firm states that indigenous making of the heart drug will b...Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
New data on Eloxatin(R), Taxotere(R) and on three investigationalagents (VEGF Trap, S-1 and TroVax(R)) will be presented at the 43rdannual ASCO meeting BRIDGEWATER, N.J., May 29, 2007 /PRNewswire-FirstCall/ --Sanofi-aventis announced today that a total of 375 abstractsindicative of its oncology commitment have been accepted for the43rd Annual Meeting of the American Society of Clinical On...